Antidepressants for Anxiety should be continued for at least a year after treatment response

News Hour:

Patients with anxiety disorders who respond to antidepressants and then stop treatment face increased the risk of relapse in the year after treatment discontinuation, finds a meta-analysis in The BMJ.

The analysis included 28 studies in which 5200 patients with anxiety disorders who responded to antidepressants were randomized to either continue treatment or switch to a placebo, after which they were assessed for relapse. Most of the studies had drug company involvement.

During up to 1 year of follow-up, relapse occurred significantly more often with placebo than with treatment continuation (36% vs. 16% of patients). In addition, time to treatment relapse was significantly shorter with placebo.

The authors conclude, “On the basis of the evidence presented here, the advice is to continue antidepressants for at least a year [after treatment response]. After this period, no evidence-based advice can be provided.”

Avatar

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Join Epidemiology Congress 2019

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Advertisement

News of the Month

September 2017
S M T W T F S
« Aug   Oct »
 12
3456789
10111213141516
17181920212223
24252627282930
Scroll Up
%d bloggers like this: